Priscila Mattar
Priscila Mattar is an endocrinologist and the vice-president of the medical area at Novo Nordisk, a leading pharmaceutical company. She has been actively involved in the discussion of diabetes and obesity treatments, particularly focusing on medications like Wegovy and Ozempic, which utilize the active ingredient semaglutida. In recent news, she highlighted the differences in dosing and efficacy between these medications, emphasizing the importance of proper medical supervision in their use for weight management and diabetes control.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Liechtenstein:
Priscila Mattar is an endocrinologist and vice-president of the medical area at Novo Nordisk.
8